John R. Desjarlais, Ph.D.

John R. Desjarlais, Ph.D.

Chief Scientific OfficeratXencor· In proxies 2021–2025

Pay in FY2025-30% from the year before · Xencor stock -33.4% the same year

John R. Desjarlais, Ph.D. was paid $2.0M in FY2025 (Dec), down 30%. Xencor stock fell 33.4% that year.

Pay$100 in the stock at the end of FY20 → $35
Pay is from the Summary Compensation Table of each Xencor proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. XencorPublic company · 5 yr
    • Chief Scientific Officer2021 – Present · 5 yrStock in role -35%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?